SCHEMBL21888004

SCHEMBL21888004

c1ccc(-n2c3ccccc3c3cc(-c4cc5c6ccccc6c6cc7c(cc6c5c5ccccc45)oc4ccccc47)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ AHR P35869 2/20 0.33
▸ SIRT2 Q8IXJ6 1/20 0.33
▸ SIRT1 Q96EB6 1/20 0.33
▸ MEN1 O00255 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ POLB P06746 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAPT P10636 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ PTGER4 P35408 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15460245 0.91 KDM4E (0.42) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL14725730 0.87 KDM4E (0.40) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL16472820 0.87 KDM4E (0.40) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL21180578 0.87 KDM4E (0.40) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL21180700 0.87 KDM4E (0.40) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL16574980 0.86 KDM4E (0.42) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL15460332 0.86 KDM4E (0.38) KDM4EATML3MBTL1AHRMEN1
SCHEMBL12698469 0.85 KDM4E (0.43) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL1635119 0.84 KDM4E (0.50) KDM4EATML3MBTL1AHRSIRT2
SCHEMBL18381823 0.84 KDM4E (0.56) KDM4EATML3MBTL1AHRSIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111244-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-09-07 — — US disclosed
US-20200109138-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200109138-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, PIEZO1, TRPC6 KDM4E 3669/4885ATM 4014/4885L3MBTL1 673/4885
US-11111244-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, PIEZO1, TRPC6 KDM4E 3669/4885ATM 4014/4885L3MBTL1 673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback